Prelude Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.3M | 1.0M | 4.27 |
| 2023-09-30 | $3.0M | 974k | 3.09 |
| 2023-06-30 | $4.3M | 953k | 4.50 |
| 2023-03-31 | $5.2M | 916k | 5.70 |
| 2022-12-31 | $5.4M | 899k | 6.04 |
| 2022-06-30 | $4.7M | 899k | 5.22 |
| 2022-03-31 | $5.5M | 801k | 6.90 |
| 2021-09-30 | $36M | 1.1M | 31.25 |
| 2021-06-30 | $32M | 1.1M | 28.61 |
| 2021-03-31 | $38M | 867k | 43.30 |
| 2020-12-31 | $47M | 660k | 71.55 |
| 2020-09-30 | $1.4M | 45k | 30.13 |